Serialisation

INDUSTRY REPORT: Serialisation in Pharma

INDUSTRY REPORT: Serialisation in Pharma

Pharmaceuticals consistently rank within the top ten categories for counterfeit goods and the risk to products can vary from country to country. In response pharmaceutical manufacturers are investing more in product security initiatives, such as serialisation which involves coding products uniquely at the item level.

In this industry report we provide expert insight and analysis from key opinion leaders in the field on the trends in battling counterfeit drugs through serialisation.

Boehringer Ingelheim's Johannes Schoen on How to Prepare for the Falsified Medicines Directive

Boehringer Ingelheim's Johannes Schoen on How to Prepare for the Falsified Medicines Directive

In this recent interview, Johannes Schoen, Supply Network Quality Management Anti-Counterfeitng, Boehringer Ingelheim speaks to Andrea Charles from Pharma IQ, following facilitating the "Anti-Counterfeiting: Falsified Medicines Directive and beyond" roundtable at Cool Chain Logistics Europe 2013.